Elanco Animal Health Incorporat

Historical 13F Holders

Symbol
ELAN
CUSIP
28414H103
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 28414H103 since 12/18/2024, largest first.

Filer % of Class Filed
Dodge & Cox 13G/A 13.9% 5/14/2026
Event 3/31/2026
FMR LLC 13G/A
10.5% 2/5/2026
Event 12/31/2025
Primecap Management Co/CA/ 13G/A 9.2% 5/13/2026
Event 3/31/2026
BlackRock, Inc. 13G 8.9% 10/17/2025
Event 9/30/2025
T. Rowe Price Investment Management, Inc. 13G 6.4% 11/14/2025
Event 9/30/2025
Vanguard Capital Management LLC 13G 5.3% 4/29/2026
Event 3/31/2026
Dimensional Fund Advisors LP 13G 5.1% 7/14/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 31 7.56 M $169 M
2026 Q2 537 581 M $14.5 B
2026 Q1 534 546 M $13.1 B
2025 Q4 511 562 M $12.7 B
2025 Q3 432 573 M $11.5 B
2025 Q2 392 539 M $7.70 B
2025 Q1 388 500 M $5.25 B
2024 Q4 421 490 M $5.92 B
2024 Q3 426 493 M $7.24 B
2024 Q2 443 492 M $7.09 B
2024 Q1 405 498 M $8.10 B
2023 Q4 387 494 M $7.36 B
2023 Q3 382 482 M $5.42 B
2023 Q2 381 474 M $4.77 B
2023 Q1 424 481 M $4.51 B
2022 Q4 443 492 M $6.03 B
2022 Q3 459 476 M $5.91 B
2022 Q2 466 473 M $9.29 B
2022 Q1 504 475 M $12.4 B
2021 Q4 518 476 M $13.5 B
2021 Q3 485 468 M $14.9 B
2021 Q2 514 469 M $16.3 B
2021 Q1 483 467 M $13.8 B
2020 Q4 484 461 M $14.2 B
2020 Q3 390 414 M $11.6 B
2020 Q2 409 401 M $8.60 B
2020 Q1 404 405 M $9.07 B
2019 Q4 427 373 M $11.0 B
2019 Q3 408 372 M $9.89 B
2019 Q2 404 376 M $12.7 B
2019 Q1 367 374 M $12.0 B
2018 Q4 176 85.7 M $2.70 B
2018 Q3 157 72.8 M $2.54 B
2016 Q1 1 186 $6.00 k